RFQ_75F40126Q00006_FDA OCI Nationwide Evidence Storage, Transportation, Disposal Management Services
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FDA OFFICE OF ACQ GRANT SVCS
Contract Value
Not provided
Codes & Classification
Solicitation Number
RFQ_75F40126Q00006_OCI_Nationwide_Evidence_Storage_Transportation_Disposal_Management_Services
NAICS
493190 - Other Warehousing and Storage
Classification Code
R616
Additional Details
The Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a Combined Synopsis/Solicitation for the procurement of comprehensive evidence storage, transportation, and disposal management services on a nationwide scale. This opportunity, identified as RFQ_75F40126Q00006_FDA OCI Nationwide Evidence Storage, Transportation, Disposal Management Services, seeks to secure a qualified contractor capable of supporting the FDA’s Office of Criminal Investigations (OCI) in the secure handling of evidentiary materials.
The primary purpose of this procurement is to ensure the safe, secure, and compliant management of evidence collected during FDA investigations. The scope of work encompasses the receipt, storage, transportation, and eventual disposal of evidence, with an emphasis on maintaining chain-of-custody integrity and adhering to all applicable federal regulations and agency protocols. The contractor will be expected to provide facilities and logistical solutions that meet the stringent requirements for evidence management, including secure warehousing, timely and traceable transportation, and proper disposal methods.
Key requirements include the provision of warehousing and storage services classified under NAICS Code 493190 (Other Warehousing and Storage), with a focus on specialized evidence handling as indicated by Product Service Code R616. The contractor must demonstrate the capability to manage sensitive materials, ensure robust security measures, and facilitate responsive transportation and disposal services as directed by the FDA OCI.
The place of performance is specified as Beltsville, Maryland, though the nationwide scope suggests that services may be required across various locations in the United States, with central operations or coordination based in Beltsville. The contract is not set aside for any specific small business or socioeconomic category, opening the opportunity to all qualified entities.
The FDA Office of Acquisition and Grant Services is the contracting entity responsible for this procurement. Interested parties should direct inquiries to the primary contact, Andrea Howard, via email at [email protected] or by phone at 240-402-7197.
This solicitation is currently active, with a posting date of March 27, 2026, and a response deadline of March 31, 2026, at 2:03 PM. All solicitation documents and attachments are available through the official SAM.gov opportunity listing (Opportunity ID: 46efd9a2ecbd48e8acd865915c9b7a29).
Contractors considering this opportunity should have demonstrated experience in secure warehousing, evidence management, and logistics, as well as the capacity to comply with federal standards for evidence handling and disposal. The contract’s requirements and objectives are expected to remain consistent throughout its lifecycle, focusing on the reliable and secure management of FDA evidence materials.
Documents7